15 results
8-K
EX-99.1
ARAV
Aravive Inc
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
to global launches, bringing important therapies to market, building and growing businesses and brands at different stages of their life cycle. Most … assessments, life cycle management strategies and marketing plans for pharma, medical devices and over the counter products in oncology, rare diseases
8-K
ARAV
Aravive Inc
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
, global launch readiness, label optimization, multiple indication assessments, life cycle management strategies and marketing plans for pharma, medical … and supporting their commercial strategy at different times in their life cycle, from pre-launch planning to loss of exclusivity. Prior to joining Everyday Health
8-K
EX-99.2
ARAV
Aravive Inc
6 May 21
Aravive continues to expand development of AVB-500 in multiple indications and combination treatments with first-line treatment for pancreatic cancer
7:08am
& blocking it could prevent/reverse PDAC desmoplasia Therapeutic could work as part of life cycle management with AVB-500 in certain cancers © 2021
8-K
EX-99.2
ARAV
Aravive Inc
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
PDAC desmoplasia Therapeutic could work as part of life cycle management with AVB-500 in certain cancers © 2021 Aravive, Inc. 27
Forward-Looking
8-K
EX-99.1
ARAV
Aravive Inc
2 Mar 21
Regulation FD Disclosure
8:00am
as part of life cycle management with AVB-500 in certain cancers © 2021 Aravive, Inc.
31 Forward-Looking Statements 3D Medicines Collaboration to Develop
8-K
EX-99.2
271osoy59dfaowt
19 Nov 20
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
7:10am
10-K
782by
6 Mar 15
Annual report
12:00am
424B4
d7tu1rqpcck0om
22 Jan 15
Prospectus supplement with pricing info
12:00am
424B4
pdgct3
21 Mar 14
Prospectus supplement with pricing info
12:00am
DRS
x80ibkmqntce4 afc9
10 Jan 14
Draft registration statement
12:00am
- Prev
- 1
- Next